Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Inflammatory carcinoma of the breast
ADR ID BADD_A10165
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.10      Breast neoplasms malignant and unspecified (incl nipple)
16.10.01      Breast and nipple neoplasms malignant
16.10.01.019      Inflammatory carcinoma of the breast
21      Reproductive system and breast disorders
21.05      Breast disorders
21.05.01      Benign and malignant breast neoplasms
21.05.01.029      Inflammatory carcinoma of the breast
Description Metastatic breast cancer characterized by EDEMA and ERYTHEMA of the affected breast due to LYMPHATIC METASTASIS and eventual obstruction of LYMPHATIC VESSELS by the cancer cells. [MeSH]
MedDRA Code 10021980
MeSH ID D058922
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Breast carcinoma inflammatory | Inflammatory breast cancer | Inflammatory carcinoma of the breast | Inflammatory Breast Neoplasms | Breast Neoplasm, Inflammatory | Breast Neoplasms, Inflammatory | Inflammatory Breast Neoplasm | Neoplasm, Inflammatory Breast | Neoplasms, Inflammatory Breast | Inflammatory Breast Cancer (IBC) | Inflammatory Breast Carcinoma | Breast Carcinoma, Inflammatory | Breast Carcinomas, Inflammatory | Carcinoma, Inflammatory Breast | Carcinomas, Inflammatory Breast | Inflammatory Breast Carcinomas | Inflammatory Breast Cancer | Breast Cancer, Inflammatory | Breast Cancers, Inflammatory | Cancer, Inflammatory Breast | Cancers, Inflammatory Breast | Inflammatory Breast Cancers
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00511Clozapine0.002446%
The 1th Page    1    Total 1 Pages